PubMed ID:
28301073
Public Release Type:
Journal
Publication Year: 2017
Affiliation: Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.; Division of Nephrology, Department of Medicine, University of California Davis, Davis, California, USA.; Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Division of Nephrology, Department of Medicine, Yale School of Medicine and Yale New Haven Health System, New Haven, Connecticut, USA.; Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
DOI:
https://doi.org/10.1111/hdi.12527
Authors:
Lo Joan C, Beck Gerald J, Kaysen George A, Chan Christopher T, Kliger Alan S, Rocco Michael V, Li Minwei, Chertow Glenn M
Request IDs:
20991
Studies:
Frequent Hemodialysis Network: Nocturnal Study
End-stage renal disease (ESRD) is associated with perturbations in thyroid hormone concentrations and an increased prevalence of hypothyroidism. Few studies have examined the effects of hemodialysis dose or frequency on endogenous thyroid function.